Bill Segar died peacefully at home, in Indianapolis, IN on Feb 1, 2021. He was 97 years old. A very touching tribute to him was written by his son Jeff Segar [a neonatologist and successful researcher in his own right] and published in Pediatric Research. I encourage you to read Jeff’s lovely tribute. This is my personal tribute to a mentor, friend and someone I have known for over 45 years.
I met Bill in 1974 when I became an intern at the University of Wisconsin. Bill was the pediatric “nephrologist” although he would be the first to say that his real training was in pediatrics and in salt and water physiology. Within months of my coming to Madison Bill became the Department Chair and remained so for 10 years. Many of you will not have met Bill, He did not go to meetings frequently and focused his efforts in and on the Department. But you will have known some of his contributions. In 1957, while Bill and Mac Holliday were both on the faculty at Indiana University [Bill’s Medical School alma mater], they published a method to calculate the maintenance fluid and electrolyte needs for hospitalized pediatric patients. This approach was taught widely around the world. What you may not know is Bill and his collaborator, William Moore, published important studies in animals on the non osmotic control of ADH.
Bill’s understanding of fluid and electrolyte physiology was extensive. As a trainee, I did not appreciate how well he thought through issues and how well he could see a patient problem and quickly think through what needed to be done. A year after I came to Wisconsin, Bill recruited another nephrologist, Russell Chesney. The chance to spend 10 years with Bill and Russell made it abundantly clear how much each knew and understood and how well they could process and solve problems. How lucky was I.
Bill was an excellent teacher. It meant a lot to him that a student, trainee or even faculty was not only knowledgeable but could use that knowledge to help patients and support colleagues. Only much later did I realize that for Bill asking a question to make things clearer was never wrong. What really bothered him was NOT asking. Bill was incisive, analytical and at times even acerbic. But we knew he was challenging us to be better thinkers and doctors.
I am grateful for the time I got to spend with Bill and appreciate the many things I learned from him. I know I speak for many. Farewell and thank you so much, Bill.
-Aaron L. Friedman, MD, University of Minnesota
It is with great sadness that we announce the passing on October 25, 2020 of John T. Herrin, MBBS, FRACP, 84, former Director of Clinical Services within the Division of Nephrology at Boston Children’s Hospital.
After his initial medical training, John left his native Australia and moved to Boston. He spent much of his early career at the Massachusetts General Hospital, where he was chief of Pediatric Nephrology from 1974 to 1994. He then moved to Boston Children’s Hospital in 1994, where he remained a cherished member of the Division of Nephrology until he retired in 2014. John held an appointment at Harvard Medical School for 49 years.
John was a passionate medical educator and developed a preceptor practice program to enhance how hundreds of pediatric residents and dozens of nephrology fellows learned clinical nephrology. He welcomed physicians, nurses, and students from around the world to Boston to spend time observing pediatric nephrology practice and care. He had near total recall of the medical literature and was a walking encyclopedia of clinical pearls that he delighted in sharing.
John was also the consummate clinician, totally committed to his patients and their well-being. There were no constraints to the length of a clinic visit or the duration of in-patient rounds if there were questions to be answered or concerns to be assuaged. In all his interactions, he modeled rare equanimity and unfailing generosity.
For those who worked alongside John, his extraordinary skills as a physician, his careful guidance as a teacher and mentor, and his unparalleled kindness as a colleague will always be remembered. He will be sorely missed.
Members of the Division of Nephrology, Boston Children’s Hospital
ASPN has been actively monitoring the developments related to COVID-19 and the emerging outbreaks within the United States and elsewhere. We are committed to the health and wellbeing of our membership and the patients and families you serve.
We are awaiting word on plans for the upcoming PAS meeting and will share details as soon as they become available.
Members of our Clinical Affairs Committee have put together pertinent guidance below, on caring for renal patients.
ASPN- COVID-19 information
General COVID-19 updates:
World Health Organization: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
CDC Webinar on COVID19 in pregnant women and children: (link not yet available)
General Family Information: AAP: https://www.healthychildren.org/English/health-issues/conditions/chest-lungs/Pages/2019-Novel-Coronavirus.aspx
CDC: Resources for higher risk individuals: https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/high-risk-complications.html
Regional Contact Information for Hospital Preparedness Program (HHS recommends contacting local/state health departments if supplies are running low)
Information for Dialysis Centers:
CDC Dialysis Recommendations: Interim additional guidance for infection prevention and control recommendations for patients with suspected or confirmed COVID-19 in outpatient hemodialysis facilities: https://www.cdc.gov/coronavirus/2019-ncov/healthcare-facilities/dialysis.html
American Society of Nephrology- COVID-19 Information for Providers of Dialysis Service- webinar: Slides: https://www.asn-online.org/g/blast/files/ASN_COVID-19_webinar_combined_slides_03.11.2020_Final.pdf
Webinar Recording Available: COVID-19 Informational Webinar for Providers of Dialysis Services
On March 11, 2020, ASN conducted an informational webinar focusing on new COVID-19 guidance for dialysis facilities from CDC and a presentation on managing patients with COVID-19 who require dialysis. This 60-minute webinar explored the possible implications for patients receiving renal replacement therapy and the staff who care for them. The webinar featured presentations from Shannon Novosad, MD, of CDC, and Suzanne Watnick, MD, FASN, and Liz McNamara, MN, RN, of Northwest Kidney Centers.
The webinar recording and slides have been posted on the NTDS website, which also has links to all updated materials from CDC.
Kidney Transplant Information:
From American Society for Transplantation for transplant recipients: Coronavirus disease 2019: frequently asked questions.
American Society of Transplantation: COVID-19: FAQs for Organ Transplantation (geared more towards transplant providers): https://www.myast.org/sites/default/files/COVID19%20FAQ%20Tx%20Centers%20030220-1.pdf
US Department of Health and Human Services: Information for transplant programs and OPOs regarding 2019 novel Coronavirus: https://optn.transplant.hrsa.gov/news/information-for-transplant-programs-and-opos-regarding-2019-novel-coronavirus/
Association of organ procurement organizations: COVID-19 bulletin (information regarding organ procurement) https://www.aopo.org/information-about-covid-19-coronavirus-is-being-released-rapidly-we-will-post-updates-as-we-receive-them/
Strategic Plan 2016-2021
The American Society of Pediatric Nephrology is an organization of pediatric nephrologists and affiliated health care professionals. Our primary goals are to promote optimal care for children with kidney disease through advocacy, education and research; and to disseminate advances in clinical practice and scientific investigation.
- Advance optimal care for children with kidney disease
- Enhance member and public awareness of ASPN activities
- Ensure a robust pediatric nephrology workforce
- Enrich the value of membership in ASPN to all its members
- Create and maintain a robust, stable infrastructure that will allow us to accomplish our mission
1.1 Maximize effective partnerships with other professional organizations
1.2 Educate external agencies about the needs of children and pediatric nephrologists
1.3 Promote research focused on pediatric kidney disease
1.4 Support development and dissemination of clinical practice guidelines
2.1 Develop communication plan aimed at internal stakeholders
2.2 Increase transparency of internal processes to the Society membership
2.3 Leverage existing, and develop new, communication platforms
3.1 Monitor and anticipate workforce needs
3.2 Increase resident/student interest in pediatric nephrology as a career
3.3 Improve professional satisfaction and decrease attrition of pediatric nephrologists
3.4 Involve and integrate affiliate members in workforce development, expansion and retention
4.1 Increase opportunities for, and encourage member engagement in, ASPN
4.2 Maximize opportunities and support for professional networking and leadership
4.3 Support the ability of ASPN members to perform clinical activities effectively
4.4 Provide access to effective educational resources and certification based on career stage
4.5 Promote the ability of members to participate in and conduct research
5.1 Ensure financial sustainability
5.2 Support and expand the ASPN Foundation as the mechanism for philanthropic opportunities
5.3 Maximize partnerships with patients and patient advocacy groups, other non-profits
5.4 Clarify and optimize the relationship with the CLB
5.5 Strengthen central office operations
5.6 Enhance technology capabilities to meet current and future needs
Right kidney upper pole defects on contrast, consistent with acute pyelonephritis